Nucleic acid binding, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:1990904 | ribonucleoprotein complex | 2 | 1 |
Related structures:
AlphaFold database: A4I287
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 9 |
GO:0003723 | RNA binding | 4 | 9 |
GO:0005488 | binding | 1 | 9 |
GO:0097159 | organic cyclic compound binding | 2 | 9 |
GO:1901363 | heterocyclic compound binding | 2 | 9 |
GO:0003729 | mRNA binding | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_SKI1_1 | 121 | 125 | PF00082 | 0.322 |
CLV_PCSK_SKI1_1 | 169 | 173 | PF00082 | 0.293 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.632 |
DEG_SCF_TRCP1_1 | 40 | 45 | PF00400 | 0.574 |
DOC_CYCLIN_RxL_1 | 118 | 125 | PF00134 | 0.493 |
DOC_MAPK_gen_1 | 142 | 151 | PF00069 | 0.493 |
DOC_WW_Pin1_4 | 181 | 186 | PF00397 | 0.485 |
LIG_14-3-3_CanoR_1 | 121 | 130 | PF00244 | 0.504 |
LIG_FHA_1 | 202 | 208 | PF00498 | 0.447 |
LIG_FHA_2 | 151 | 157 | PF00498 | 0.549 |
LIG_LIR_Nem_3 | 125 | 130 | PF02991 | 0.544 |
LIG_PAM2_1 | 6 | 18 | PF00658 | 0.616 |
LIG_SH2_CRK | 168 | 172 | PF00017 | 0.493 |
LIG_SH3_3 | 11 | 17 | PF00018 | 0.617 |
LIG_SH3_3 | 200 | 206 | PF00018 | 0.540 |
LIG_TRAF2_1 | 153 | 156 | PF00917 | 0.493 |
MOD_CK1_1 | 140 | 146 | PF00069 | 0.477 |
MOD_CK1_1 | 201 | 207 | PF00069 | 0.462 |
MOD_CK1_1 | 38 | 44 | PF00069 | 0.614 |
MOD_CK1_1 | 65 | 71 | PF00069 | 0.569 |
MOD_CK2_1 | 150 | 156 | PF00069 | 0.529 |
MOD_CK2_1 | 191 | 197 | PF00069 | 0.447 |
MOD_GlcNHglycan | 124 | 127 | PF01048 | 0.328 |
MOD_GlcNHglycan | 193 | 196 | PF01048 | 0.449 |
MOD_GlcNHglycan | 40 | 43 | PF01048 | 0.578 |
MOD_GlcNHglycan | 64 | 67 | PF01048 | 0.571 |
MOD_GlcNHglycan | 8 | 11 | PF01048 | 0.643 |
MOD_GSK3_1 | 156 | 163 | PF00069 | 0.492 |
MOD_GSK3_1 | 181 | 188 | PF00069 | 0.509 |
MOD_GSK3_1 | 31 | 38 | PF00069 | 0.659 |
MOD_LATS_1 | 29 | 35 | PF00433 | 0.620 |
MOD_N-GLC_1 | 140 | 145 | PF02516 | 0.303 |
MOD_N-GLC_1 | 185 | 190 | PF02516 | 0.444 |
MOD_N-GLC_1 | 6 | 11 | PF02516 | 0.611 |
MOD_N-GLC_1 | 62 | 67 | PF02516 | 0.575 |
MOD_NEK2_1 | 99 | 104 | PF00069 | 0.472 |
MOD_NEK2_2 | 160 | 165 | PF00069 | 0.529 |
MOD_PIKK_1 | 212 | 218 | PF00454 | 0.460 |
MOD_PIKK_1 | 35 | 41 | PF00454 | 0.736 |
MOD_PKB_1 | 167 | 175 | PF00069 | 0.493 |
MOD_Plk_4 | 65 | 71 | PF00069 | 0.569 |
MOD_ProDKin_1 | 181 | 187 | PF00069 | 0.483 |
TRG_ENDOCYTIC_2 | 127 | 130 | PF00928 | 0.550 |
TRG_ENDOCYTIC_2 | 168 | 171 | PF00928 | 0.500 |
TRG_ENDOCYTIC_2 | 79 | 82 | PF00928 | 0.612 |
TRG_ER_diArg_1 | 55 | 58 | PF00400 | 0.563 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I044 | Leptomonas seymouri | 71% | 96% |
A0A3Q8IC83 | Leishmania donovani | 100% | 100% |
A4HF08 | Leishmania braziliensis | 86% | 100% |
E9AYD2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 99% |
Q4Q442 | Leishmania major | 37% | 100% |
Q4Q6X2 | Leishmania major | 32% | 100% |
Q4Q941 | Leishmania major | 95% | 99% |